Stocks · News reference
Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M Estimate
Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.32) by 40.63 percent. This is a 13.64 percent increase over losses of $(0.22) per share from the same
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
NeurAxis Announces Its Medical Policy Coverage Now Serves Over 26M Medical Plan Members
8-K filing — Neuraxis, INC (NRXS)
Filed: 2026-10-14 AccNo: 0001493152-26-047034 Size: 201 KB Item 8.01: Other Events
NeurAxis shares are trading higher. The company announced new medical policy coverage from a national health insurer for Percutaneous Electrical Nerve Field Stimulation, spanning multiple states and covering ~18 million members.